July 1 (Reuters) - The U.S. Food and Drug Administration approved expanded use of Vertex Pharmaceuticals' gene therapy in ...

Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these ...

In recognition of Juneteenth and World Sickle Cell Disease Awareness Day, ImpactLife stressed the importance of transfusions ...

The American Red Cross is encouraging people to donate blood this Juneteenth, with a special focus on increasing donations ...

The U.S. Food and Drug Administration today issued a supplemental approval for Casgevy (exagamglogene autotemcel) for ...

SOUTHINGTON, Conn. (WTNH) — A Plainville teen with a rare genetic blood disorder celebrated her 14th birthday with an ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. The ...

Black Americans make up the majority of sickle cell patients in the U.S. The Red Cross says blood drives are a way to help.

Sickle cell disease is a blood disorder that affects millions across the globe. Dr Nakul Pathak helps spread awareness of the ...

A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. A single one-time gene therapy could free ...

Stem cell transplantation could be a rapid and effective way to restore hemoglobin production in individuals with the blood disorder β-thalassaemia. The treatment, presented in a phase 1 clinical ...

Scientists have long been puzzled by how maturing red blood cells manage to produce all the hemoglobin they need to carry oxygen to tissues, even after shedding the vital structures they need to ...